Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 269: | Line 269: | ||
* | * | ||
* low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | * low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | ||
* Inflammation<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | * [[Inflammation]]<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | ||
* Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | * Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | ||
* Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | * Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | ||
Line 281: | Line 281: | ||
* Thin<br>appendiceal<br>wall | * Thin<br>appendiceal<br>wall | ||
* A focus<br>of<br>hyper-<br>echogenicity | * A focus<br>of<br>hyper-<br>echogenicity | ||
* '''Since<br> generally<br> there is<br> no inflammation''' | * '''Since<br> generally<br> there is<br> no [[inflammation]]''' | ||
* Surrounding <br>fat<br> is normal. | * Surrounding <br>fat<br> is normal. | ||
* No peri-<br>appendiceal <br>fluid or<br>collection | * No peri-<br>appendiceal <br>fluid or<br>collection | ||
Line 314: | Line 314: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | | rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | ||
pseudo-<br>myxoma<br> peritonei:<br> | [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br> peritonei]]:<br> | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting<br>dullness | * [[Shifting dullness|Shifting<br>dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 365: | Line 365: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Pelvic/ abdominal pain or pressure | * Pelvic/ [[abdominal pain]] or pressure | ||
* Vaginal bleeding/ discharge | * [[Vaginal bleeding]]/ discharge | ||
* Dyspnea | * [[Dyspnea|Dyspne]]<nowiki/>a | ||
* GI disturbance | * GI disturbance | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 373: | Line 373: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
* Fever | * [[Fever]] | ||
* Pleural effusion | * [[Pleural effusion]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 383: | Line 383: | ||
* [[Lactate dehydrogenase|LDH]] | * [[Lactate dehydrogenase|LDH]] | ||
* [[Calcium]] | * [[Calcium]] | ||
* Estrogen | * [[Estrogen]] | ||
* Progestron | * Progestron | ||
* Testos-<br>terone | * [[Testosterone|Testos-<br>terone]] | ||
* AFP | * [[Alpha-fetoprotein|AFP]] | ||
* CA 125 | * [[CA-125]] | ||
* Ki 67 | * Ki 67 | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 397: | Line 397: | ||
* Pleural <br>effusion | * Pleural <br>effusion | ||
* Peritoneal<br>involvement | * Peritoneal<br>involvement | ||
* Lympha-denopathy | * [[Lymphadenopathy|Lympha-denopathy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal <br> mass | * Adnexal <br> mass | ||
Line 440: | Line 440: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | | style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | ||
''Adeno-'' | ''[[Adenocarcinoma|Adeno-]]'' | ||
''carcinoma'' | ''[[Adenocarcinoma|carcinoma]]'' | ||
* [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | * [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | ||
* [[Ulcer|Ulcerating<br>polyps]] | * [[Ulcer|Ulcerating<br>polyps]] | ||
Line 449: | Line 449: | ||
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | * [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | -/+([[Carcinoid Tumor|Carcinoid tumor]]<nowiki/>s) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Anemia]] | * [[Anemia]] | ||
Line 461: | Line 461: | ||
*[[Metastases|Hepatic<br>metastases]], | *[[Metastases|Hepatic<br>metastases]], | ||
*Intestinal<br>perforation,<br> | *Intestinal<br>perforation,<br> | ||
*Enlarged<br>lymph<br>nodes | *[[Lymphadenopathy|Enlarged<br>lymph<br>nodes]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | * [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | ||
Line 467: | Line 467: | ||
* [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | * [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | ||
| style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | | style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | ||
| style="background: #F5F5F5; padding: 5px;" |PET<br>scan,<br>Endoscopy,<br>Colonoscopy, | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|PET<br>scan]],<br>[[Endoscopy]],<br>[[Colonoscopy]], | ||
Barium enema | [[Lower gastrointestinal series|Barium enema]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 484: | Line 484: | ||
| style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | | style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | ||
Shifting dullness | [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Nonspecific | * Nonspecific | ||
* Depends<br>on the<br>etiology<br>of the<br>disease | * Depends<br>on the<br>[[etiology]]<br>of the<br>disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> pseudo-<br>myxoma <br>from other<br> causes of<br> | * Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma]] <br>from other<br> causes of<br>[[peritonitis]]. | ||
* Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | * Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>MRI.<br>MRI has<br> better<br>sensitivity<br>in<br>detecting<br>ascites<br>fluid <br> | Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>[[Magnetic resonance imaging|MRI]].<br>[[Magnetic resonance imaging|MRI]] has<br> better<br>sensitivity<br>in<br>detecting<br>[[ascites]]<br>fluid <br>and<br>[[mucocele]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The echoes<br>within<br>pseudo-<br>myxoma <br>peritonei <br>are not <br>mobile. | * The echoes<br>within<br>[[Pseudomyxoma peritonei|pseudo-<br>myxoma <br>peritonei]] <br>are not <br>mobile. | ||
* Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | * Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | ||
* Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins | * Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins |
Revision as of 19:37, 21 February 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
Differentiating appendix cancer from other Diseases
- Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
- As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.
- Carcinoid tumors must be differentiated from other diseases that cause carcinoid syndrome sign and symptoms such as palpitation, facial flushing, and diarrhea.
- In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers and appendix mucoceles.
Diseases | Clinical manifestations | Para-clinical findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histo-
pathology | |||||||||||||
Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities | |||
Appendix cancer | Adeno- | +/- | -/+ | <math>\downarrow</math> |
|
- | - | - |
|
|
|
Positron emission tomography (PET) |
Gross pathology:
Microscopic
IHC:
| ||
Carcinoid
tumor2 |
+/- | - | <math>\uparrow</math> |
|
- | - | + |
Ki67: |
|
Gross pathology:
Microscopic
IHC:
| |||||
Goblet
cell carcinoid |
+ | +/- | <math>\uparrow</math> |
|
+/- | + |
|
+/- |
|
Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. |
Gross
Microscopic
| ||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology | |
Appendix Mucocele | Mucosal
hyperlasia |
- | - | - |
|
- | +/- | N/A | - | N/A |
|
Rounded right iliac fossa mass
|
|
N/A | Similar to hyperplastic colon polyp |
Simple
or retention cyst |
- | - | - | - | +/- | - | - | N/A | Degenerative epithelial changes because of obstruction | ||||||
Mucinous cyst=
adenomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+/- | +/- | If develop | - |
| ||||||
Mucinous cystadeno-
carcinomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> | +/- | +/- | - | - |
| |||||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra- sounography |
Other diagnostic studies and imaging modalities |
Histo-
pathology | |
Ovarian cancer | +/- | +/- | +/-<math>\downarrow</math> |
|
+ | +/- | - |
|
|
|
N/A | Depends on the tumor type. You may find the details here. | |||
Colorectal cancer | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+ | +/- | Colonoscopy
Carcinoids
|
-/+(Carcinoid tumors) |
|
Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. |
PET scan, Endoscopy, Colonoscopy, |
| |||
Pseudomyxoma | + | + | <math>\uparrow</math><math>\downarrow</math> | Bloating | - | + | Ascites | - |
|
|
Charact- |
|
18F-FDG PET scan |
IHC: | |
Carcinoid syndrome | -/+ | - | <math>\uparrow</math> | Flushing
Palpitation Dyspnea |
- | - |
|
+ | Depends on the tumor type:
|
Depends on the primary tumor location and type |
|
IHC:
| |||
Appendicitis 3 | PU, RLQ |
- | <math>\uparrow</math><math>\downarrow</math> | Nausea & vomiting, decreased appetite |
+/- | + |
|
- |
|
|
Increased fluid signal on T2 weighted sequence |
Evidences of inflammation
|
Tc-99m labeled anti- CD15 antibodies |
Evidences of inflammation | |
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
frequ- f ency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology |
1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile Pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
4 Imaging is not a reliable method to distinguish between neoplastic and nonneoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha Fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA 125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation